Overview

Melphalan in Patients With Neoplastic Meningitis

Status:
Completed

Trial end date:
2001-05-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of melphalan in patients with persistent or recurrent neoplastic meningitis.

Phase:

Phase 1

Details

Lead Sponsor:

Duke University

Treatments:

Melphalan